Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Other financing activities (2019 - 2025)

Haemonetics (HAE) has 14 years of Other financing activities data on record, last reported at -$89000.0 in Q4 2025.

  • For Q4 2025, Other financing activities rose 40.27% year-over-year to -$89000.0; the TTM value through Dec 2025 reached -$116000.0, up 60.68%, while the annual FY2025 figure was -$249000.0, 241.1% down from the prior year.
  • Other financing activities reached -$89000.0 in Q4 2025 per HAE's latest filing, down from $36000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $23.1 million in Q2 2024 and bottomed at -$23.2 million in Q3 2024.
  • Average Other financing activities over 5 years is $788388.9, with a median of -$11500.0 recorded in 2022.
  • The widest YoY moves for Other financing activities: up 23100.0% in 2023, down 6538.46% in 2023.
  • A 5-year view of Other financing activities shows it stood at -$31000.0 in 2021, then surged by 70.97% to -$9000.0 in 2022, then skyrocketed by 9688.89% to $863000.0 in 2023, then tumbled by 117.27% to -$149000.0 in 2024, then soared by 40.27% to -$89000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other financing activities were -$89000.0 in Q4 2025, $36000.0 in Q3 2025, and -$36000.0 in Q2 2025.